SEC Form 4 · accession 0001179110-16-024187
Assertio Therapeutics, Inc · ASRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
August J Moretti
Officer — Chief Financial Officer & SVP
Period of report
May 9, 2016
Accepted (ET)
May 9, 2016 · 4:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005201
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1,F2 | May 9, 2016 | S | 5,000 | $18.00 | D | 22,879 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of restricted stock sold pursuant to a 10b5-1 plan adopted on March 12,2015.
- F2Amount does not include any unvested restricted stock previously reported on Form 4 by the reporting person.